Boston Globe reporter Alex Kingsbury writes that MIT researchers have developed a paper-based test to diagnose Zika. The test could not only make it easier for doctors to diagnose the disease in developing countries, but also “distinguish between the four types of dengue fever, even if Zika wasn’t present — a useful diagnostic tool for doctors in its own right.”
MIT researchers have developed a portable paper-based test that can diagnose the Zika virus and differentiate between four types of the Dengue virus, writes Rowan Walrath for Boston Magazine. The researchers are, “also working on a diagnostic for the tick-borne Powassan virus, which…causes a severe form of encephalitis.”
A new blood test developed by MIT researchers can distinguish between the Zika and dengue viruses, reports Andrew Joseph for STAT. “Being able to distinguish the four serotypes is very important for epidemiology purposes and to know what viruses are circulating in an environment,” explains Prof. Lee Gehrke.
MIT researchers have developed a new test that can identify dengue and the Zika virus quickly and cheaply, reports Sophie Hares for Reuters. “Knowing whether these tests are positive or negative is very important for designing the course of clinical care,” explains Prof. Lee Gehrke. “It simplifies the decision tree and, we believe, leads to improved patient care.”
Damien Garde of STAT highlights Prof. Li-Huei Tsai’s research on the HDAC2 enzyme in an article about Alzheimer’s research. “If we can reduce HDAC2 expression in Alzheimer’s disease models, we can reactivate the genes [that] actually rescue learning and memory,” says Prof. Tsai.
Carey Goldberg of WBUR speaks to Prof. Kevin Esvelt and graduate student Joanna Buchthal about the next steps in engineering mice that are immune to Lyme disease. With the Lyme disease antibodies identified, the next step is “to encode that mouse DNA back in the mouse genome so that it can be inherited by future generations,” says Esvelt.
CBS Boston highlights a new study by MIT researchers that shows that blocking the HDAC2 enzyme could one day help restore memories in Alzheimer’s patients. Postdoctoral fellow Jay Penney explains that, “What we’ve done is found a new way to basically prevent this negative effect of this enzyme.”
MIT researchers have found that blocking the HDAC2 enzyme could potentially restore the memories of Alzheimer’s patients, reports Alyssa Meyers for The Boston Globe. The researchers, “pinpointed a gene called Sp3 that binds with HDAC2, which then results in the compression and subsequent deactivation of memory genes.”
Boston Magazine reporter Jamie Ducharme writes that MIT researchers have found that blocking the HDAC2 enzyme may potentially reverse memory loss in Alzheimer’s patients. The researchers, “blocked HDAC2 activity by preventing it from binding with Sp3, a protein coding gene that the team found to be a crucial part of genetic blockade formation.”
Boston Magazine reporter Jamie Ducharme writes that MIT researchers have developed a non-invasive technique for assessing cells, which could eventually be used to help diagnose diseases. The researchers are “working with doctors at Massachusetts General Hospital, who hope to use the technique to study diseases such as cancer and asthma.”
Scientific American reporter Lindsay Brownell writes that MIT researchers have developed a technique to enlarge pathology samples. “Not only are expanded samples easier to see because they are larger and more transparent, fluorescent tags and other labels can also be added to track individual molecules of interest.”
Boston Herald reporter Lindsay Kalter writes that MIT researchers have developed a hydrogel-based capsule that can slowly release medications over several days and could help patients follow complex treatment regimens. “A lot of people do not take their medication as prescribed,” explains postdoc Jinyao Liu. “With this, you just need a single dose.”
Anne Pycha of Scientific American writes about three new methods that could be used to help detect Parkinson’s disease and enable early intervention. A new typing test developed by MIT researchers could be used to identify individuals with possible signs of Parkinson’s, “by analyzing key hold times (the time required to press and release a key).”
FOX 25’s Bob Dumas reports on a study by MIT Medical that shows most parents could successfully perform strep tests at home. David Diamond, associate medical director of MIT Medical, explains that in the healthcare field, “we are empowering patients to help us take care of their health,” adding that this test, “would be yet another advance in this regard.”
Henri Termeer, a life member of the MIT Corporation who was known as one of the founding fathers of the biotech industry, died at age 71, write Robert Weisman and Bryan Marquard for The Boston Globe. Termeer was, “a key leader in the biotech revolution that placed Massachusetts at the nexus of cutting-edge research and development.”